Review article: Gastric acidity - Comparison of esomeprazole with other proton pump inhibitors

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 1, 2003, Pages 10-15

  Hatlebakk, J G ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMAN; METHODOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH PH; TISSUE INJURY; TREATMENT OUTCOME;

EID: 0037330207     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.17.s1.3.x     Document Type: Conference Paper

References (19)

1. Hatlebakk JG, Hyggen A, Madsen PH, et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999; 319: 550-3.
2. Hatlebakk JG, Johnsson F, Vilien M, Carling L, Wetterhus S, Thøgersen T. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease, Scand J Gastroenterol 1997; 32: 1100-6.
3. Sachs G. Improving on PPI-based therapy of GORD. Eur J Gastroenterol Hepatol 2001; 13(Suppl. 1): S35-41.
4. Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001; 96: 656-65.
5. Kahrilas PJ, Falk GW, Johnson DA, et al. Esomeprazole improves healing and symptom resolution as compared to omeprazole in reflux oesophagitis patients: a randomized controlled trial. The Esomeprazole Study Investigators. Aliment Pharmacol Ther 2000; 14: 1249-58.
6. Johnson DA, Benjamin SB, Vakil NB, et al. Esomeprazole once daily for 6 months is effective therapy for maintaining healing of esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized double-blind, placebo-controlled study of efficacy and safety. Am J Gastroenterol 2001; 96: 27-34.
7. Johnsson L, Adlouni W, Johnsson F, loelsson B. Timing of reflux symptoms and esophageal acid exposure. Gullet 1992; 2: 58-62.
8. Pursnani KG. Mohiuddin MA, Geisinger KR, Weinbaum G. Katzka DA, Castefl DO. Experimental study of acid burden and acute oesophagitis, Br J Surg 1998; 85: 677-80.
9. Smith JL, Opekun AR, Larkai E, Graham DY. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989: 96; 683-9.
10. Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease, Digestion 1992; 51(Suppl. 1): 59-67.
11. Hatlebakk JG, Katz PO, Castell DO, Medical therapy, Management of the refractory patient. Gastroenterol Clin North Am 1999; 28: 847-60.
12. Lind T, Rydberg L, Kylebäck A. et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 861-7.
13. Armstrong D, Emde C, Blum AL. Review twenty-four-hour intragastric pH-metry studies: easy to do but difficult to analyse. Eur J Gastroenterol Hepatol 1989; 1: 167-74.
14. Thomson ABR, Claar-Nilsson C, Hasselgren G, Niazi M, Röhss K, Nyman L. Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg during single and repeated administration. Gut 2000; 47(Suppl. I:II): A63 (Abstract).
15. Röhss K, Claar-Nilsson C, Rydholm H, Nyman L. Esomeprazole 40 mg provides more effective acid control than lansoprazole 30 mg. Gastroenterology 2000; 118: A20 (Abstract).
16. Wilder-Smith C, Röhss K, Lundin C, Rydholm H. Esomeprazole (E) 40 mg provides more effective acid control than pantoprazole (P) 40 mg. Gastroenterology 2000; 118: A22-3 (Abstract).
17. Wilder-Slnith C, Röhss K, Claar-Nilsson C, Rydholm H. Esomeprazole 40 mg provides more effective acid control than rabeprazole 20 mg. Gut 2000; 47(Suppl. III): A63 (Abstract).
18. Wilder-Smith C, Claar-Nilsson C, Hasselgren G, Röhss K, Esomeprazole 40 mg provides faster and more effective acid control than rabeprazole 20 mg in patients with symptoms of GERD. Am J Gastroenterol 2001; 96(Suppl. 5): S45.
19. Wilder-Smith C, Röhss K, Claar-Nilsson C, Rydholm H. Esomeprazole 20 mg provides more effective acid control than lansoprazole 15 mg. Gut 2000; 47(Suppl. III): A62 (Abstract).